All Studies

Sort by :

Study Name

Study Title

Status

Recruit.

Contact

AURORA

Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer

PRECISION-PDX

Personalised medicine for brain tumour patients: from basic research to preclinical models

REASSURE

Radium-223 alpha Emitter Agent in Safety Study in metastatic Castration Resistant Prostate Cancer (mCRPC) population...

HOVON 156 AML

REFINE

REFINE: Regorafenib observational study in hepatocellular carcinoma

CASSIOPEIA (Hovon 131)

Study of Daratumumab in combination with Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD) in the first Line treatment of transplant eli...

Hovon 132 AML

Randomized study with a run-in dose-selection phase to assess the added value of
lenalidomide in combination with standard remission-indu...

PATSGO

Randomized multicentric Phase II study of prolonged adjuvant Temozolomide or "stop and go" in glioblastoma...

RACATREX

Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell ...

FIELT 2

Treating lung cancer in non-smokers: the next step

LUME BioNIS: a Biomarker Study in Patients With NSCLC

A Non-interventional Biomarker Study in Patients With Non-Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Tumour Histology Eligible for Treatmen...

MDS-010 (PASS 2)

A prospective non-interventional post-authorization safety study (PASS), designed as a disease registry of patients with transfusion dependent IP...

212082PCR4001

A Prospective Registry of Patients With a Confirmed Diagnosis of Adenocarcinoma of the Prostate Presenting With Meta...

ASCEND-5

A Phase III, Multicenter, Randomized, Open-label Study of Oral LDK378 Versus Standard Chemotherapy in Adult Patients...

CAPRELSA

European, Observational, Prospective Study to Evaluate the Benefit/Risk of Vandetanib (CAPRELSA™) 300 mg in RET Mutation Negative and RET M...

CORRELATE

Safety and Effectiveness of Regorafenib in Routine Clinical Practice Setting

MELANOMA

A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectab...

IBBL LCA

Immunological risk factors for smokers to develop lung tumors

LUX-lung CUP

An Open Label Compassionate Use Programme of afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated wi...

PRO-ELECT

A PROspective randomised ELectronic Evaluation of ChemoTherapy Side effects in oncology out-patients

LUME

A double-blind, randomized, placebo controlled Phase III study of Nintedanib plus best supportive care (BSC) versus ...

Abiraterone Acetate (JNJ-212082) (Protocol 212082BCA2001)

Randomized, Open-Label Study of Abiraterone Acetate (JNJ-212082) Plus Prednisone With or Without Exemestane in Postm...

NP28673

An open-label, non-randomized, multicenter phase I/II trial of RO5424802 given orally to non-small cell lu...

MILO

A Multinational, Randomized, Open-label Phase 3 Study of MEK162 vs. Physician’s Choice Chemotherapy in Patient...

MO28231

A multicenter single arm study of trastuzumab emtansine (T-DM1) in Her2 positive locally advanced or metastatic brea...

Per page: 5 10 25

Studies overview

This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.

All Studies

Search

Studies overview